MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20233973

August 1, 2023

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.1%(5ml:5mg,按C₂₁H₂₃NO₃计)

化学药品

August 1, 2023

Company Information

Applicant Company

合肥市高新区科学大道61号

Manufacturing Company

合肥市高新区科学大道61号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath